Letters to the EditorMorphologic and Immunohistochemical Assessment of CDH1 Loss of Function Alterations in Prostatic AdenocarcinomaGupta, Sounak MBBS, PhD*; Fine, Samson W. MD*; Chang, Jason MD*; Tickoo, Satish K. MD*; Chen, Ying-Bei MD, PhD*; Al-Ahmadie, Hikmat A. MD*; Sirintrapun, Sahussapont J. MD*; Abida, Wassim MD†; Ladanyi, Marc MD*; Reuter, Victor E. MD*; Gopalan, Anuradha MD*Author Information Departments of *Pathology †Medicine, Memorial Sloan Kettering Cancer Center New York, NY S.G., S.W.F., J.C., and A.G.: performed the research. S.G., S.W.F., J.C., and A.G.: designed the research study. S.G., S.W.F., J.C., S.K.T., Y.-B.C., H.A.A.-A., S.J.S., W.A., M.L., V.E.R., and A.G.: analyzed the data. S.G., S.W.F., J.C., and A.G.: wrote the manuscript. Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article. Online date: December 24, 2019 The American Journal of Surgical Pathology: March 2020 - Volume 44 - Issue 3 - p 420-422 doi: 10.1097/PAS.0000000000001427 Buy Metrics Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.